ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 2395

Plasma Short-Talin Is a New Rheumatoid Arthritis Monitoring Biomarker Independent Of The Inflammatory Markers

Kensei Tsuzaka, Masako Takao and Jiro Nishida, Dept of Internal Medicine, Ichikawa General Hospital,TDC, Ichikawa, Chiba, Japan

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: ACPA, Activity score, biomarkers and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Session Title: Rheumatoid Arthritis: Human Etiology and Pathogenesis II

Session Type: Abstract Submissions (ACR)

Background/Purpose: Talin has been known as a cytoskeletal protein, which, by binding to integrin beta-subunit, enhances the inside-out signaling from intracellular to extracellular of integrins, cell adhesion, cell migration, and causes chronic inflammation and angiogenesis. Last 2012ACR meeting, we have reported that intracellular talin in RA patients is cleaved into short-talin and expressed predominantly in plasma. In 2011ACR meeting, we have demonstrated higher sensitivity and specificity of the plasma short-talin than those of anti-CCP antibody (ACPA). Although several RA biomarkers have been reported, some of them are not independent of the inflammatory markers like CRP and ESR due to the usage of the algorithm combined with them. In this paper, we investigated whether the plasma short-talin can be an RA biomarker independent of the inflammatory markers.

Methods: RA was diagnosed as the 2010 Rheumatoid Arthritis Classification Criteria. Plasma and sera were obtained simultaneously from 51 RA patients (Age, 60.9±14.4 y/o; DAS28, 4.54 ± 1.20). Sixteen (31.4 %) of these 51 patients were untreated, and 18 patients (35.3%) were treated with biologics DMARD at the time of collecting blood samples. Plasma short-talin was quantified using a sandwich ELISA with anti-short talin capture and detecting antibodies. Serum ACPA was measured using a commercial ELISA kit. RA activity at the time of collecting blood samples was estimated using DAS28, SDAI, and CDAI.

Results: The expression of the plasma short-talin was significantly correlated with DAS28 (r=0.37, p=0.0070), SDAI (r=0.36, p=0.011), CDAI (r=0.32, p=0.030), and ACPA (r=0.63, p=0.001) (Fig.1). However, plasma short-talin level was not correlated with ESR, CRP, and MMP-3.

Conclusion: The expression of the plasma short-talin could reveal the RA activity and can not only be an RA diagnostic marker, but also an RA monitoring biomarker independent of the inflammatory markers like ESR and CRP.


Disclosure:

K. Tsuzaka,

Kaytee Bio,

4;

M. Takao,
None;

J. Nishida,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/plasma-short-talin-is-a-new-rheumatoid-arthritis-monitoring-biomarker-independent-of-the-inflammatory-markers/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences